IBD Drive Time: Adam Cheifetz, MD, on Therapeutic Drug Monitoring

Host Raymond Cross, MD, and guest Adam Cheifetz, MD, discuss how to utilize therapeutic drug monitoring (TDM) to evaluate and titrate drug levels among patients with inflammatory bowel disease being treated with tumor necrosis factor inhibitors—and the pros and cons of proactive TDM.

Raymond Cross, MD, is a professor of medicine and director of the IBD Program at the University of Maryland School of Medicine in Baltimore, Maryland. Adam Cheifetz, MD, is director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School in Boston, Massachusetts.